-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
August 01, 2013 - be bedridden as patients with stroke from other
etiologies, and are also more likely to result in death … 0.60)
All-cause mortality 1 (12,098) SOE = Moderate
No difference (RR 0.88; 95% CI 0.77 to 1.00)
Death … 0.47)
All-cause mortality 1 (12,037) SOE = Moderate
No difference (RR 0.91; 95% CI 0.80 to 1.03)
Death … to 0.93)
All-cause mortality 1 (14,264) SOE = High
No difference (HR 0.92; 95% CI 0.82 to 1.03)
Death … 5,599) SOE = Low
Trend toward a reduction in risk with apixaban
(HR 0.79; 95% CI 0.62 to 1.02)
Death
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-disposition-comments.pdf
June 14, 2021 - Disposition of Comments_Comparative Effectiveness Review NO. 243: Prehospital Airway Management
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Prehospital Airway Management: A Systematic Review
Draft report available for public comment from December 2020 to January 2021.
…
-
effectivehealthcare-admin.ahrq.gov/products/chronic-pain-opioid-treatment/research-protocol
December 01, 2019 - For example, recent data have shown an association between opioid use and overdose death that is dose-dependent
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/comparison-of-tight-management-vs-less-control-among-pts-with-type-2-dm-who-are-hospitalized-with-blood-glucose-related-illnesses
November 01, 2017 - harms of dm treatment include: pain, hyperglycemia, hypoglycemia, death
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/for-adult-female-patients-what-is-the-comparative-effective-of-non-surgical-and-surgical-treatment-of-chronic-pelvic-pain
November 01, 2017 - If surgery is performed (hysterectomy), risk of complications and death.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
March 01, 2009 - signs, symptoms, conditions, or events that individuals experience, such as myocardial infarction, death … Death, coronary heart disease, bradycardia, stroke,
transient ischemic attack, venous thromboembolism … from coronary causes,
non-fatal MI, ACS)
5057 5044 5 553 533 0.95 0.84-1.07
Death CVD ( … Rate
Weight Gain 2121 2050 34 months 81 NR 109 NR NR NR NR
Mortality
Total Death- STAR
Trial … Rate
STAR
101 2.64 96 2.49 0.94 0.71-1.26
Total Death- Tamoxifen
Trial Name
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-quantitative-synthesis_methods.pdf
October 01, 2010 - to survival, the estimate of RR will be affected substantially and
RR for death is not the reciprocal … Effect of rosiglitazone
on the risk of myocardial infarction and
death from cardiovascular causes … Uncertain
effects of rosiglitazone on the risk for
myocardial infarction and cardiovascular
death … effects meta-analysis in rare event
studies: the rosiglitazone link with
myocardial infarction and cardiac … death.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/methodsguide_conductingquantitativesynthesis.pdf
October 01, 2010 - to survival, the estimate of RR will be affected substantially and
RR for death is not the reciprocal … Effect of rosiglitazone
on the risk of myocardial infarction and
death from cardiovascular causes … Uncertain
effects of rosiglitazone on the risk for
myocardial infarction and cardiovascular
death … effects meta-analysis in rare event
studies: the rosiglitazone link with
myocardial infarction and cardiac … death.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-200-post-acs-depression.pdf
November 01, 2017 - outcome: Decrease in depression symptoms
Secondary outcomes: Major adverse cardiac event (MACE) or death … patients Low Direct None detected
MACE 1 study RCT Unknown Precise HR 1.01 (CI
0.86 to 1.18) for
death
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
August 01, 2017 - anaphylactic or anaphylactoid reactions
�� Possible profound sedation, respiratory depression, coma, and death … fracture requiring
hospitalization, hip fracture, cancer
�» Ramelteon: prolactinoma
�» Temazepam: death
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ischemic-stroke-treatment_executive.pdf
January 01, 2011 - 0
mRS Studies 5 1 11 5 3 4 2 0 9 1 0 1 1 0 0
Patients 440 18 11 213 173 16 12 0 33 14 0 1 34 0 0
Death … #Death included if patients were followed up for any duration of time after hospital discharge. … outcomes
Clinical Outcomes
NIHSS
Predictor Variables Recanalization Improvement Hemorrhage* mRS≤2 Death
-
effectivehealthcare-admin.ahrq.gov/products/acute-pain-treatment/protocol
May 01, 2019 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/products/lung-cancer-nonsurgical-therapies/research-protocol
December 01, 2019 - over 1 million deaths per year. 1 In the United States, lung cancer is the leading cause of cancer death … Analytical Frameworks and PICOTS above)
Response criteria
Followup frequency and duration
Cause of death
-
effectivehealthcare-admin.ahrq.gov/products/c-difficile-update/research-protocol
December 01, 2019 - range from mild diarrhea to severe cases including pseudomembranous colitis and toxic megacolon and death … percent of deaths from C. difficile occurred in persons ≥65 years of age, the 17 th leading cause of death
-
effectivehealthcare-admin.ahrq.gov/health-topics/mammography
June 01, 2012 - Skip to main content
An official website of the Department of Health & Human Services
Careers
Contact Us
Español
FAQs
Effective Health Care Program
Powered by the Evidence-based Practice Centers
…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-iv-nursing-staff-shortages.pdf
October 01, 2024 - Temporary Staffing and Patient Death in Acute Care Hospitals: A
Retrospective Longitudinal Study.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_research-protocol.pdf
March 13, 2012 - followup (the study will require at least 2 years of followup for the
outcomes of cancer recurrence or death … sensitivity, specificity, accuracy, etc.) of the GEP results to the risk of disease
recurrence and/or death … II or Duke B
colon cancer (colorectal cancer) study population, and reported cancer recurrence or
death
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-measures-framework_research.pdf
April 01, 2010 - All the indicators approved
by the NQF defined the denominator retrospectively from the time of death … hospices,
5.4% and 13.3%).20 These indicators are based on a psychometrically evaluated tool, the After-
Death … Some indicator sets are
retrospective from the time of death, which limits their use prospectively or
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-framework_research.pdf
April 01, 2010 - All the indicators approved
by the NQF defined the denominator retrospectively from the time of death … hospices,
5.4% and 13.3%).20 These indicators are based on a psychometrically evaluated tool, the After-
Death … Some indicator sets are
retrospective from the time of death, which limits their use prospectively or
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
December 01, 2011 - Such cancers are an infrequent cause of death,
and those affected are more likely to die of
unrelated … Trends
Progress Report (2009/10) indicates that, after increasing
from 1975 to 1991, prostate cancer death … Similarly, black patients with prostate cancer were at
higher risk for death due to prostate cancer compared … patients with moderately and poorly
differentiated tumors had a higher probability of prostate
cancer death